Congress May Preserve Intoxicating Hemp Loophole, Raising Employer Concerns

Farm Bill Markup Signals Status Quo on Hemp-Derived Intoxicants

Congressional staff familiar with the Farm Bill negotiations told Forbes that neither chamber's draft language includes provisions to close the intoxicating hemp loophole created by the 2018 Farm Bill. That law legalized hemp containing less than 0.3% delta-9 THC by dry weight but inadvertently opened the door to semi-synthetic cannabinoids like delta-8 THC, which can be manufactured from CBD isolate through chemical conversion.

The current draft suggests lawmakers can't agree on how to regulate these products. Senate Agriculture Committee Chair Amy Klobuchar has floated age restrictions and labeling requirements, but House Republicans have resisted any new federal oversight of hemp-derived intoxicants, viewing the issue as a state matter.

If the loophole survives? Employers in all 50 states will keep facing legal uncertainty over whether workers can use delta-8 THC products off-duty and still pass workplace drug screens.

Employer Drug-Testing Programs Face Legal Gray Zone

Most standard drug panels don't distinguish between delta-9 THC from marijuana and delta-8 THC from legal hemp, creating potential liability for employers who terminate workers based on positive tests. Employment attorneys interviewed by Forbes noted that wrongful-termination claims have already been filed in at least seven states where employees argued they consumed only legal hemp products.

Key employer concerns include:

• Standard immunoassay tests detect THC metabolites without differentiating cannabinoid isomers
• Confirmatory GC-MS testing can identify delta-8 vs. delta-9, but most employers don't use this protocol
• Federal contractors and DOT-regulated industries remain bound by zero-tolerance policies regardless of hemp legality
• State laws vary wildly on whether legal hemp use constitutes grounds for adverse employment action

The National Safety Council has urged employers to update drug-free workplace policies to explicitly address hemp-derived intoxicants. Fewer than 15% of companies have done so according to a 2026 survey by the Society for Human Resource Management.

State Regulatory Responses Create Compliance Patchwork

At least 18 states have enacted their own restrictions on intoxicating hemp products since 2023, but enforcement remains inconsistent. Colorado, Oregon, and Washington have effectively banned delta-8 THC by requiring all intoxicating cannabinoids to flow through state-licensed marijuana markets. Minnesota and Vermont have imposed age restrictions and potency caps but allow retail sales.

Florida's legislature passed a ban on delta-8 THC in 2025, only to see Governor Ron DeSantis veto the measure after lobbying from hemp farmers and CBD retailers. Texas has taken the opposite approach, with the Department of State Health Services issuing guidance that delta-8 THC remains a Schedule I controlled substance under state law despite federal hemp legalization.

Multi-state employers face operational headaches. A worker legally purchasing delta-8 gummies in Tennessee could face termination for the same conduct if transferred to a Colorado facility.

Safety-Sensitive Industries Maintain Zero-Tolerance Stance

Transportation, construction, and healthcare employers have largely maintained blanket prohibitions on all THC use regardless of source, citing federal safety regulations and insurance requirements. The Federal Motor Carrier Safety Administration confirmed in 2025 guidance that commercial drivers can't use any intoxicating cannabinoid, including hemp-derived delta-8 THC, even in states where such products are legal.

Aviation employers face similar constraints under FAA medical certification rules. Healthcare systems have pointed to Joint Commission accreditation standards requiring drug-free workplaces as justification for zero-tolerance policies.

Employment law experts note these industries have the strongest legal footing to prohibit all THC use, but employers in non-safety-sensitive sectors face greater risk of wrongful-termination claims if they fire workers for legal hemp consumption.

Testing Technology Lags Behind Legal Developments

The drug-testing industry has been slow to develop affordable point-of-collection tests that can differentiate delta-8 THC from delta-9 THC. Quest Diagnostics and LabCorp both offer confirmatory testing that can identify specific cannabinoid isomers, but the process requires gas chromatography-mass spectrometry and adds 3-5 days to turnaround time plus $150-$300 per sample in additional cost.

Oral fluid testing has emerged as a potential solution, with some manufacturers claiming their devices can detect recent impairment rather than metabolites from days-old use. But the Substance Abuse and Mental Health Services Administration hasn't yet certified oral fluid testing for federal workplace programs, limiting adoption.

Until testing technology catches up, employers must choose between expensive confirmatory testing for every positive screen or accepting the legal risk of terminating workers who may have used only legal hemp products.

What Employers Should Do Now

Employment attorneys recommend employers review and update drug-free workplace policies immediately to address hemp-derived intoxicants, even if Congress preserves the loophole. Key action items include:

• Explicitly define prohibited substances to include all intoxicating cannabinoids regardless of source
• Specify whether the policy applies only to on-duty conduct or extends to off-duty use
• Consider switching to confirmatory testing protocols that differentiate cannabinoid isomers
• Train supervisors on reasonable-suspicion protocols focused on observable impairment rather than positive tests alone
• Consult with employment counsel in each state where the company operates to ensure policies comply with local hemp laws

For full background on this evolving regulatory landscape, see the CannIntel topic hub on the federal hemp loophole.